{"ANU": {"name": "Laeeq Malik", "link": "https://researchers.anu.edu.au/researchers/malik-l", "colleges": "College of Health & Medicine", "email": "Laeeq.Malik@anu.edu.au", "phone": "", "expertise": [], "interest": [], "biography": "", "project": [], "publication": []}, "Microsoft-Academic": [{"title": "relationship of pharmacokinetics pk toxicity and initial evidence of clinical activity with imgn853 a folate receptor alpha fra targeting antibody drug conjugate in patients pts with epithelial ovarian cancer eoc and other fra positive solid tumors", "year": 2014, "source": "journal of clinical oncology", "authors": [{"name": "kathleen n moore", "affiliation": "university of oklahoma health sciences center"}, {"name": "joseph ponte"}, {"name": "patricia lorusso", "affiliation": "wayne state university"}, {"name": "michael j birrer", "affiliation": "harvard university"}, {"name": "todd michael bauer", "affiliation": "ohio state university"}, {"name": "hossein borghaei", "affiliation": "fox chase cancer center"}, {"name": "david m omalley", "affiliation": "ohio state university"}, {"name": "rodrigo ruizsoto", "affiliation": "glaxosmithkline"}, {"name": "robert j lutz"}, {"name": "laeeq malik", "affiliation": "university of texas health science center at san antonio"}], "id": 15137598}, {"title": "lsd1 activation promotes inducible emt programs and modulates the tumour microenvironment in breast cancer", "year": 2018, "source": "scientific reports", "authors": [{"name": "tara boulding", "affiliation": "university of canberra"}, {"name": "robert mccuaig", "affiliation": "university of canberra"}, {"name": "abel tan", "affiliation": "university of canberra"}, {"name": "kristine hardy", "affiliation": "university of canberra"}, {"name": "fan wu", "affiliation": "university of canberra"}, {"name": "j dunn", "affiliation": "university of canberra"}, {"name": "murugan kalimutho", "affiliation": "qimr berghofer medical research institute"}, {"name": "christopher sutton", "affiliation": "university of canberra"}, {"name": "jade k forwood", "affiliation": "charles sturt university"}, {"name": "andrew g bert", "affiliation": "south australia pathology"}, {"name": "gregory j goodall", "affiliation": "south australia pathology"}, {"name": "laeeq malik", "affiliation": "canberra hospital"}, {"name": "desmond yip", "affiliation": "australian national university"}, {"name": "desmond yip", "affiliation": "canberra hospital"}, {"name": "jane e dahlstrom", "affiliation": "canberra hospital"}, {"name": "anjum zafar", "affiliation": "university of canberra"}, {"name": "k k khanna", "affiliation": "qimr berghofer medical research institute"}, {"name": "sudha rao", "affiliation": "university of canberra"}], "id": 196734849}, {"title": "phase ii study evaluating the efficacy safety and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma", "year": 2014, "source": "cancer chemotherapy and pharmacology", "authors": [{"name": "devalingam mahalingam", "affiliation": "university of texas health science center at san antonio"}, {"name": "laeeq malik", "affiliation": "university of texas health science center at san antonio"}, {"name": "muralidhar beeram", "affiliation": "university of texas health science center at san antonio"}, {"name": "j rodon", "affiliation": "university of texas health science center at san antonio"}, {"name": "kamalesh kumar sankhala", "affiliation": "university of texas health science center at san antonio"}, {"name": "alain c mita", "affiliation": "university of texas health science center at san antonio"}, {"name": "daniel benjamin", "affiliation": "university of texas health science center at san antonio"}, {"name": "norma s ketchum", "affiliation": "university of texas health science center at san antonio"}, {"name": "joel e michalek", "affiliation": "university of texas health science center at san antonio"}, {"name": "anthony w tolcher", "affiliation": "university of texas health science center at san antonio"}, {"name": "john j wright", "affiliation": "national institutes of health"}, {"name": "john sarantopoulos", "affiliation": "university of texas health science center at san antonio"}], "id": 117498271}, {"title": "role of immunotherapy in bladder cancer past present and future", "year": 2018, "source": "cancer chemotherapy and pharmacology", "authors": [{"name": "sabeehurrehman butt", "affiliation": "canberra hospital"}, {"name": "laeeq malik", "affiliation": "australian national university"}, {"name": "laeeq malik", "affiliation": "canberra hospital"}], "id": 117498271}, {"title": "abstract ot2 02 01 a real world experience of cdk4 6 inhibition with ribociclib and endocrine therapy in hormone receptor positive metastatic breast cancer in australia", "year": 2020, "source": "cancer research", "authors": [{"name": "sheau wen lok", "affiliation": "peter maccallum cancer centre"}, {"name": "sally baronhay"}, {"name": "elgene lim"}, {"name": "robert blum"}, {"name": "frances m boyle", "affiliation": "mater health services"}, {"name": "kerrie clarke"}, {"name": "katharine cuff", "affiliation": "princess alexandra hospital"}, {"name": "michael r green"}, {"name": "laeeq malik", "affiliation": "canberra hospital"}, {"name": "kelly mok", "affiliation": "liverpool hospital"}, {"name": "nick murray", "affiliation": "royal adelaide hospital"}, {"name": "louise m nott", "affiliation": "royal hobart hospital"}, {"name": "michelle nottage"}, {"name": "ali tafreshi", "affiliation": "university of wollongong"}, {"name": "daphne tsoi", "affiliation": "st john of god health care"}, {"name": "belinda yeo"}, {"name": "peter gibbs", "affiliation": "walter and eliza hall institute of medical research"}, {"name": "richard de boer"}], "id": 168522863}, {"title": "abstract ps6 35 real world outcomes in elderly women with her2 positive advanced breast cancer", "year": 2021, "source": "cancer research", "authors": [{"name": "nicole evans"}, {"name": "angelyn anton"}, {"name": "rachel wong", "affiliation": "monash university"}, {"name": "sheau wen lok", "affiliation": "peter maccallum cancer centre"}, {"name": "richard de boer", "affiliation": "peter maccallum cancer centre"}, {"name": "laeeq malik", "affiliation": "canberra hospital"}, {"name": "sarah l m greenberg"}, {"name": "belinda yeo"}, {"name": "louise m nott", "affiliation": "royal hobart hospital"}, {"name": "gary richardson"}, {"name": "ian m collins"}, {"name": "javier torres", "affiliation": "goulburn valley health"}, {"name": "frances barnett", "affiliation": "northern hospital"}, {"name": "peter gibbs", "affiliation": "university of melbourne"}, {"name": "bianca devitt", "affiliation": "monash university"}], "id": 168522863}, {"title": "addition of endocrine therapy to dual anti her2 targeted therapy in initial treatment of her2 hr metastatic breast cancer", "year": 2020, "source": "journal of clinical oncology", "authors": [{"name": "matthew loft", "affiliation": "walter and eliza hall institute of medical research"}, {"name": "sheau wen lok"}, {"name": "richard de boer", "affiliation": "royal melbourne hospital"}, {"name": "laeeq malik", "affiliation": "canberra hospital"}, {"name": "sarah l m greenberg"}, {"name": "belinda yeo", "affiliation": "the royal marsden nhs foundation trust"}, {"name": "angelyn anton", "affiliation": "peter maccallum cancer centre"}, {"name": "louise m nott", "affiliation": "royal hobart hospital"}, {"name": "gary richardson"}, {"name": "ian m collins"}, {"name": "javier torres", "affiliation": "goulburn valley health"}, {"name": "frances barnett"}, {"name": "bianca devitt", "affiliation": "monash university"}, {"name": "peter gibbs", "affiliation": "royal melbourne hospital"}, {"name": "lucy gately", "affiliation": "university of melbourne"}], "id": 15137598}, {"title": "optimizing poly adp ribose polymerase inhibition through combined epigenetic and immunotherapy", "year": 2018, "source": "cancer science", "authors": [{"name": "thiruvarudsothy prasanna", "affiliation": "university of canberra"}, {"name": "thiruvarudsothy prasanna", "affiliation": "canberra hospital"}, {"name": "fan wu", "affiliation": "university of canberra"}, {"name": "kum kum khanna", "affiliation": "qimr berghofer medical research institute"}, {"name": "desmond yip", "affiliation": "australian national university"}, {"name": "desmond yip", "affiliation": "canberra hospital"}, {"name": "laeeq malik", "affiliation": "australian national university"}, {"name": "laeeq malik", "affiliation": "canberra hospital"}, {"name": "jane e dahlstrom", "affiliation": "australian national university"}, {"name": "jane e dahlstrom", "affiliation": "canberra hospital"}, {"name": "sudha rao", "affiliation": "university of canberra"}], "id": 175946340}, {"title": "targeting nuclear lsd1 to reprogram cancer cells and reinvigorate exhausted t cells via a novel lsd1 eomes switch", "year": 2020, "source": "frontiers in immunology", "authors": [{"name": "wen juan tu", "affiliation": "university of canberra"}, {"name": "wen juan tu", "affiliation": "qimr berghofer medical research institute"}, {"name": "robert mccuaig", "affiliation": "university of canberra"}, {"name": "robert mccuaig", "affiliation": "qimr berghofer medical research institute"}, {"name": "abel tan", "affiliation": "university of canberra"}, {"name": "kristine hardy", "affiliation": "university of canberra"}, {"name": "nabila seddiki", "affiliation": "french institute of health and medical research"}, {"name": "nabila seddiki", "affiliation": "university of paris"}, {"name": "sayed ali"}, {"name": "jane e dahlstrom", "affiliation": "australian national university"}, {"name": "jane e dahlstrom", "affiliation": "canberra hospital"}, {"name": "elaine g bean", "affiliation": "canberra hospital"}, {"name": "jenny dunn", "affiliation": "qimr berghofer medical research institute"}, {"name": "jade k forwood", "affiliation": "charles sturt university"}, {"name": "sofia tsimbalyuk", "affiliation": "charles sturt university"}, {"name": "kate smith", "affiliation": "charles sturt university"}, {"name": "kate smith", "affiliation": "australian nuclear science and technology organisation"}, {"name": "desmond yip", "affiliation": "australian national university"}, {"name": "desmond yip", "affiliation": "canberra hospital"}, {"name": "laeeq malik", "affiliation": "australian national university"}, {"name": "laeeq malik", "affiliation": "canberra hospital"}, {"name": "thiru prasanna", "affiliation": "charles sturt university"}, {"name": "thiru prasanna", "affiliation": "canberra hospital"}, {"name": "peter j milburn", "affiliation": "australian national university"}, {"name": "sudha rao", "affiliation": "university of canberra"}, {"name": "sudha rao", "affiliation": "qimr berghofer medical research institute"}], "id": 2595292759}, {"title": "real world impact of anti her2 therapy related cardiotoxicity in patients with advanced her2 positive breast cancer", "year": 2020, "source": "asia pacific journal of clinical oncology", "authors": [{"name": "c conduit", "affiliation": "peter maccallum cancer centre"}, {"name": "c conduit", "affiliation": "royal hobart hospital"}, {"name": "r de boer"}, {"name": "sheau wen lok", "affiliation": "peter maccallum cancer centre"}, {"name": "peter gibbs", "affiliation": "walter and eliza hall institute of medical research"}, {"name": "laeeq malik", "affiliation": "canberra hospital"}, {"name": "zoe loh"}, {"name": "belinda yeo"}, {"name": "sarah l m greenberg"}, {"name": "bianca devitt"}, {"name": "janine m lombard"}, {"name": "michelle nottage"}, {"name": "ian m collins", "affiliation": "deakin university"}, {"name": "javier torres", "affiliation": "goulburn valley health"}, {"name": "m nolan"}, {"name": "louise m nott", "affiliation": "royal hobart hospital"}], "id": 77500791}], "ANDS-Grants": []}